Body Dysmorphic Disorder and Aesthetic Surgery: A Review

Overview · What BDD is, and is not · How common it is · What happens after surgery · Screening · What does help · For surgeons and staff · Evidence · Related articles · question library below

Almost everyone considering aesthetic surgery dislikes something about their appearance. That is the ordinary reason people seek it, and it is not a disorder. Body dysmorphic disorder is something different in kind: a preoccupation with a perceived flaw that others barely notice or do not see at all, which consumes hours of most days and interferes with work, relationships, or ordinary life.

The distinction matters for one practical reason. Aesthetic surgery reliably changes appearance. It does not reliably change the preoccupation, and for people with BDD the preoccupation is the problem. This page exists because BDD sits at the intersection of two things AesthetiFact takes seriously: it is among the best documented predictors of a dissatisfied surgical outcome, and it is a treatable condition that is frequently missed.

BDD is classified in the DSM-5 within the obsessive-compulsive and related disorders. The core features are a preoccupation with one or more perceived defects in appearance that are not observable or appear slight to others, repetitive behaviours in response (mirror checking, mirror avoidance, camouflaging, skin picking, reassurance seeking, comparing), and clinically significant distress or impairment. The nose, skin, hair, eyes, chin and breasts are among the most frequently reported concerns, which is precisely why aesthetic clinics see it.

What it is not: wanting a change that is visible to others; being nervous before surgery; having high standards; or having a specific, well defined goal such as a dorsal hump or heavy upper eyelids. A person can be an excellent surgical candidate and still care a great deal about how they look. Distress alone is not the marker. Disproportion between the concern and what is objectively there, plus the time it consumes and the life it costs, is the marker.

Two related patterns are worth naming. Insight in BDD is often poor or absent, meaning the person is genuinely convinced the flaw is real and visible, and so is not persuaded by reassurance. And concerns commonly migrate: when one feature is altered, attention frequently moves to another.

Point prevalence in the general population is usually estimated at around 2 percent. In aesthetic surgery and cosmetic dermatology settings, reported prevalence is several times higher, commonly cited in the range of roughly 5 to 15 percent, with higher figures reported in rhinoplasty series specifically (Grade C: estimates come from cross-sectional studies using different instruments, different thresholds and different populations, and they vary widely for exactly those reasons).

The honest reading of that literature is not a precise number. It is a direction and a magnitude: a surgeon seeing aesthetic patients will encounter BDD substantially more often than a clinician in general practice, and often enough that screening is not an academic exercise. See Rhinoplasty, where the concentration is highest.

The observational literature is consistent: most patients with BDD who undergo a cosmetic procedure do not experience lasting improvement in their preoccupation. Reported outcomes include symptoms unchanged, symptoms worsened, satisfaction with the operated feature but no change in overall distress, and displacement of the concern onto a different feature. A minority pursue repeated revision surgery in search of a result that the operation was never able to deliver (Grade C: this evidence is observational and cannot be randomised, since randomising people with BDD to surgery would not be ethical; it is nonetheless consistent across series and settings).

Two further findings matter to everyone in the room. Dissatisfaction in this group is associated with a disproportionate share of complaints, repeated consultations and litigation. And there is a documented, if uncommon, association with suicidality in BDD, which does not resolve because an operation went technically well. This is the reason most professional guidance treats active, untreated BDD as a contraindication to elective aesthetic surgery rather than merely a caution.

Screening is brief and validated instruments exist. The BDDQ (Body Dysmorphic Disorder Questionnaire) is a short self-report screen, with the BDDQ-AS adapted for aesthetic surgery settings. The COPS (Cosmetic Procedure Screening Questionnaire) was designed specifically for this population, and the Dysmorphic Concern Questionnaire is also used. These take a few minutes and are designed to be sensitive, so a positive screen is a prompt for a longer conversation, not a diagnosis (Grade B for instrument validation; Grade C for how well any of them perform in routine consultation, which is less studied than the instruments themselves).

Screening instruments do not replace the consultation. The questions that tend to surface the pattern are about proportion and cost rather than about the feature: how many hours a day does this occupy, what have you stopped doing because of it, what happens when you are away from a mirror, and what specifically will be different in your life afterwards. An answer describing a global change in how life goes, rather than a change in a feature, is the one that warrants pause.

BDD is treatable, which is the part most often left out of discussions framed around refusing surgery. Cognitive behavioural therapy specifically adapted for BDD has randomised controlled trial support, as do serotonin reuptake inhibitors, which in BDD are typically used at higher doses and for longer trials than in depression (Grade B). Treatment is generally more effective than surgery at addressing the preoccupation, and it is not mutually exclusive with reconsidering a procedure later, from a different starting point.

If any of this describes your experience, the useful next step is a conversation with a doctor or a mental health professional rather than a decision about surgery. BDD responds to treatment, and it is commonly missed for years because people bring the concern to aesthetic clinics rather than to clinicians who recognise it. If you are having thoughts of harming yourself, please contact your doctor or your local emergency or crisis service now.

A declined operation is a clinical act and deserves the care of one. Practical points that recur in the literature and in society guidance: screen routinely rather than selectively, since selective screening finds what it expects to find; treat a positive screen as the start of a conversation; avoid debating whether the flaw is real, which reinforces the loop and rarely persuades; frame referral around distress and its cost rather than around the appearance; and document the discussion. Front desk and patient coordinator staff often see the pattern first, in repeated calls, repeated photographs, and consultations at multiple practices.

Related considerations sit in Patient Safety, particularly around expectation setting, and in Revision Surgery, where repeated dissatisfaction with technically sound results is a signal worth reading.

• Grade B: validation of BDD screening instruments; randomised trial support for BDD-specific cognitive behavioural therapy and for serotonin reuptake inhibitors.
• Grade C: prevalence estimates in aesthetic surgery populations, which vary widely by instrument and setting; post-surgical outcomes in BDD, which are observational by necessity.
• Expert opinion: the specific wording of screening questions and the conduct of the declining conversation, which rest on clinical guidance rather than trial data.

This page describes a psychiatric condition in general terms. It cannot tell any individual reader whether they have it, and it is not a substitute for assessment by a qualified clinician.

Patient Safety: A Review · Revision Surgery · Rhinoplasty: A Review · Preoperative Preparation.

The complete question library for this topic follows below.